MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
Q4 2019 | $0 | – | 15 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $6,000 | -93.8% | 225 | -89.3% | 0.00% | -100.0% |
Q3 2018 | $96,000 | +31.5% | 2,094 | +6.9% | 0.00% | +33.3% |
Q2 2018 | $73,000 | +73.8% | 1,959 | +58.8% | 0.00% | +50.0% |
Q1 2018 | $42,000 | 0.0% | 1,234 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $42,000 | +110.0% | 1,234 | +124.8% | 0.00% | +100.0% |
Q3 2017 | $20,000 | +300.0% | 549 | +175.9% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 199 | -17.1% | 0.00% | – |
Q1 2017 | $5,000 | +25.0% | 240 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -77.8% | 240 | -72.4% | 0.00% | -100.0% |
Q3 2016 | $18,000 | -33.3% | 870 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $27,000 | -22.9% | 870 | +8.8% | 0.00% | 0.0% |
Q4 2015 | $35,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |